KV Pharmaceutical To Decide Whether To Retain Generics Business After Settling Manufacturing Cover-up Charges With DoJ

KV Pharmaceutical is ceasing the operations of its generics subsidiary, Ethex Corp., in the wake of a plea agreement with the Department of Justice and it is uncertain what will become of the business